Diagnostic Innovations Group

This collaborative program of research aims to accelerate equitable access to diagnostic tests and health care for all, with a particular focus on improving care for people who are marginalised or living in remote or resource-constrained settings. In partnership with a large range of community, industry, academic and policy stakeholders, together we explore diagnostic innovations, evaluating their performance, feasibility and impact with the goal of simplifying testing algorithms to improve time to result and linkage to care. This Group works closely with partners to identify novel diagnostic tests, analytical tools and software that better characterise the viability of pathogens and markers of resistance to improve antimicrobial stewardship. The team also aims to optimise the integration of diagnostic testing, such as point-of-care testing, into routine clinical practice and to enhance infectious disease surveillance.